BÁO CÁO Y HỌC: " CHAMP: COGNITIVE BEHAVIOUR THERAPY FOR HEALTH ANXIETY IN MEDICAL PATIENTS, A RANDOMISED CONTROLLED TRIAL" PDF

Int. J. Med. Sci. 2006, 3 63International Journal of Medical Sciences ISSN 1449-1907 www.medsci.org 2006 3(2):63-68 ©2006 Ivyspring International Publisher. All rights reserved Review A Practical Approach to Managing Patients with HCV Infection Richard H. Huang, and Ke-Qin Hu Division of Gast[r]

Cirrhosis), is a multicenter study of the potential benefit of prolonged peginterferon therapy in mitigating the progression of fibrotic liver disease. [8] In this study, 391 of the 1045 patients enrolled into the initial “lead-in” phase had biopsy proven cirrhosis. Preliminary results show t[r]

non-responders to peginterferon alpha 2b and ribavirin. In: AASLD (Abstract 413); Oct 29- Nov 2 2004; Boston, MA. 36. Gross JB et al. Renew Trial- High dose re-treatment with peginterferon alpha 2b plus ribavirin for non responders in chronic HCV patients. In: AASLD 2003 (Abstract 321); Oct 24-28 20[r]

4. Serfaty L, Aumaitre H, Chazouilleres O, Bonnand AM, Rosmorduc O, Poupon RE, et al. Determinants of outcome of compensated hepatitis C virus-related cirrhosis. Hepatology 1998;27:1435-1440. 5. Kasahara A, Hayashi N, Mochizuki K, Takayanagi M, Yoshioka K, Kakumu S, Iijima A, Urushihar[r]

Int. J. Med. Sci. 2006, 3 79International Journal of Medical Sciences ISSN 1449-1907 www.medsci.org 2006 3(2):79-83 ©2006 Ivyspring International Publisher. All rights reserved Review Management of HCV Infection and Liver Transplantation Thomas D. Schiano, and Paul Martin Adult Liver Transplantation[r]

nate length of time for widespread realization, it is now generally recognized that overweight/obesity have reached epidemic proportions in the United States [11]. Further, this health problem is not limited to America, because globally there are over one billion overweight adults according to many[r]

Int. J. Med. Sci. 2006, 3 79International Journal of Medical Sciences ISSN 1449-1907 www.medsci.org 2006 3(2):79-83 ©2006 Ivyspring International Publisher. All rights reserved Review Management of HCV Infection and Liver Transplantation Thomas D. Schiano, and Paul Martin Adult Liver Transplantation[r]

3. Department of Medical Technology, Nagoya University School of Health Sciences, 1-1-20 Daikominami, Higashi-ku, Na-goya, 461-8673 Japan Correspondence to: Simon Itou, Department of Preventive Medicine / Biostatistics and Medical Decision Making, Nagoya University Graduate School of Medicine, 65 Ts[r]

English cities: a case-control comparison of possible causal factors. BJU International 1999;84:95-8. 16. Wennerholm UB, Bergh C, Hamberger L, Lundin K, Nilsson L, Wikland M, et al. Incidence of congenital malformations in children born after ICSI. Hum Reprod 2000; 15:944-8. 17. Klip H, Verlo[r]

virus. In this study, HCVRNA was detected more frequently in patients with anti-HCV positive (90.7% of 130) than in patients with HBsAg/anti-HCV positive (65.2% of 69, p<0.001). 5. Antivirus Therapy Few data exist on treatment of double infection. Some preliminary studies [45,46] showed that[r]

Int. J. Med. Sci. 2006, 3 108International Journal of Medical Sciences ISSN 1449-1907 www.medsci.org 2006 3(3):108-111 ©2006 Ivyspring International Publisher. All rights reserved Research paper Association of the T+294C polymorphism in PPAR δ with low HDL cholesterol and coronary heart disease risk[r]

2005; 352(20):2049–2060. 15. Sarnak MJ, Katz R, Stehman-Breen CO, et al. Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med. 2005; 142(7):497–505. 16. Mooradian AD. Digitalis. An update of clinical pharmacokinetics, therapeutic monitoring techniques an[r]

during the medication and succeeded in H. pylori eradication. Since the smokers during the medication were four at most, eradication rate for smokers could not be estimated with an enough statistical power. In conclusion, the present study confirmed the low eradication rate among the RM who were tre[r]

Int. J. Med. Sci. 2006, 3 117International Journal of Medical Sciences ISSN 1449-1907 www.medsci.org 2006 3(4):117-123 ©2006 Ivyspring International Publisher. All rights reserved Review PARP-1 inhibitors: are they the long-sought genetically specific drugs for BRCA1/2-associated breast cancers? Jos[r]

subjects walked briskly for 20 minutes at 45-80% heart rate (HR) reserve (to achieve an intensity of 11-14 of Rating of Perceived Exertion Scale), more than 5 days a week. They also performed a 30 minute resistance training (3 times per week) consisting of a 5-minute warm-up and[r]

University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550 Japan. Tel: +81-52-744-2133, Fax: +81-52-744-2971, e-mail: y-goto@med.nagoya-u.ac.jp Received: 2006.09.22; Accepted: 2006.10.25; Published: 2006.11.01 Background: Various single nucleotide polymorphisms (SNPs) have ex[r]

Int. J. Med. Sci. 2006, 3 148International Journal of Medical Sciences ISSN 1449-1907 www.medsci.org 2006 3(4):148-151 ©2006 Ivyspring International Publisher. All rights reserved Short Research Communication Mutation Analysis of hCDC4 in AML Cells Identifies a New Intronic Polymorphism Dani[r]

24, the likelihood of an SVR is virtually nil and treatment can be stopped or continued with the only aim to slow liver disease progression in patients with a severe prognosis, without any hope to eradicate infection (Figure 1A) [18, 22]. Ongoing trials are studying whether a pr[r]

acute HCV infection persists and 4% to 20% of patients with chronic hepatitis C will develop liver cirrhosis within 20 years. In patients with liver cirrhosis, the risk to develop HCC is 1-5% per year. Current standard therapy is the combination of pegylated interferon-α (PEG-IFN-α) and ribavirin. D[r]

1a, 1b, 2a...).[4] Frequent HCV mutations and numerous subtypes have made the search for an HCV vaccine challenging. There is strong evidence demonstrating the association of chronic HCV infection to cirrhosis and hepatocellular carcinoma (HCC). HCV is a mounting global health c[r]